Estimating the Prevalence of Cardiac Amyloidosis in Old Patients with Heart Failure-Barriers and Opportunities for Improvement: The PREVAMIC Study

Background: Cardiac amyloidosis (CA) could be a common cause of heart failure (HF). The objective of the study was to estimate the prevalence of CA in patients with HF. Methods: Observational, prospective, and multicenter study involving 30 Spanish hospitals. A total of 453 patients ? 65 years with...

Descripción completa

Detalles Bibliográficos
Autores: Ruiz-Hueso, R., Salamanca-Bautista, P., Quesada-Simón, M.A., Yun, S., Conde-Martel, A., Morales-Rull, J.L., Suárez Gil, Roi, García-García, J.Á., Llàcer, P., Fonseca-Aizpuru, E.M., Amores-Arriaga, B., Martínez-González, Á., Armengou-Arxe, A., Peña-Somovilla, J.L., López-Reboiro, M.L., Aramburu-Bodas, Ó.
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Servizo Galego de Saúde (SERGAS)
Repositorio:RUNA. Repositorio da Consellería de Sanidade e Sergas
OAI Identifier:oai:runa.sergas.gal:20.500.11940/21445
Acceso en línea:https://portalcientifico.sergas.gal//documentos/64609fccc6d6be6c90fc74a4
http://hdl.handle.net/20.500.11940/21445
Access Level:acceso abierto
Palabra clave:AS Lugo
CHULA
Descripción
Sumario:Background: Cardiac amyloidosis (CA) could be a common cause of heart failure (HF). The objective of the study was to estimate the prevalence of CA in patients with HF. Methods: Observational, prospective, and multicenter study involving 30 Spanish hospitals. A total of 453 patients ? 65 years with HF and an interventricular septum or posterior wall thickness > 12 mm were included. All patients underwent a 99mTc-DPD/PYP/HMDP scintigraphy and monoclonal bands were studied, following the current criteria for non-invasive diagnosis. In inconclusive cases, biopsies were performed. Results: The vast majority of CA were diagnosed non-invasively. The prevalence was 20.1%. Most of the CA were transthyretin (ATTR-CM, 84.6%), with a minority of cardiac light-chain amyloidosis (AL-CM, 2.2%). The remaining (13.2%) was untyped. The prevalence was significantly higher in men (60.1% vs 39.9%, p = 0.019). Of the patients with CA, 26.5% had a left ventricular ejection fraction less than 50%. Conclusions: CA was the cause of HF in one out of five patients and should be screened in the elderly with HF and myocardial thickening, regardless of sex and LVEF. Few transthyretin-gene-sequencing studies were performed in older patients. In many patients, it was not possible to determine the amyloid subtype.